Back to Results
First PageMeta Content
Pharmacology / Health / Clinical pharmacology / Therapeutics / United States Public Health Service / Medical device / New Drug Application / Pharmaceutical industry / ImClone Systems / Pharmaceutical sciences / Food and Drug Administration / Medicine


A BNA INC. PHARMACEUTICAL LAW & INDUSTRY!
Add to Reading List

Document Date: 2004-03-17 13:01:42

Open Document

File Size: 57,94 KB

Share Result on Facebook

City

Washington / D.C. / /

Company

National Affairs Inc. / ImClone Systems Inc. / BNA INC. PHARMACEUTICAL / Latham & Watkins LLP / /

Event

Judicial Event / M&A / /

IndustryTerm

biotechnology / electronic communications / developmental product / drug product / particular products / improved investor communications / pharmaceutical / developmental products / investor communications / premarket approval applications / /

Organization

Bureau of National Affairs / Food and Drug Administration / Food and Drug Division / SEC Division of Enforcement / office of Regulatory Affairs / FDA / Department of Health and Human Services / office of the General / U.S. Securities and Exchange Commission / Securities and Exchange Commission / office of General / /

Person

John Taylor / CAROLYNE R. HATHAWAY / Sam D. Waksal / J. BEN HAAS / JOHN R. MANTHEI / Mark McClellan / /

/

Position

Counsel / liaison officer / director / chief executive officer / Commissioner / associate commissioner for regulatory affairs / /

Product

Erbitux / /

PublishedMedium

the FDA review / /

Technology

biotechnology / /

URL

http /

SocialTag